Latest Healthcare News

CD Private Equity Fund I reported a 43% decline in net profit for FY25 but maintained steady distributions, underpinned by key portfolio exits and a resilient US private equity market.

Austco Healthcare has completed its strategic acquisition of New Zealand’s G&S Technologies, enhancing its healthcare communication offerings and direct sales reach in the region.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

Beamtree Holdings has forged a strategic alliance with the NHS Confederation to launch a pioneering healthcare analytics platform across UK NHS Trusts, marking a significant step in its international expansion.

HealthCo Healthcare & Wellness REIT and its partners have arranged a short-term partial rent deferral with Healthscope’s receivers to maintain hospital operations during a critical transition period.

8I Holdings Limited reported a net loss of S$1.09 million for FY2025, impacted by a sharp decline in investment gains due to global market volatility and new U.S. tariffs. The Group remains focused on a conservative, value-driven investment strategy despite challenging conditions.

Wellnex Life Limited has had its trading suspension lifted following its response to ASX queries related to a recent shareholder letter, reopening market access to its shares.

Wellnex Limited has withdrawn its recent announcement referencing a SP Angel research report containing forward-looking financial information, clarifying it does not endorse the projections.

The ASX has challenged Wellnex Life Limited over its recent shareholder announcement featuring forward-looking financial forecasts from SP Angel, prompting a mandated retraction due to disclosure shortcomings.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.